Skip to content

Programa para reducir la ansiedad en mujeres con cáncer de mama: un estudio piloto

J. Gonzáles, Javier González-Ramírez, Rosario Edith Ortiz-Félix, Ulises Rieke-Campoy, Adriana Camargo Bravo, José Luis Higuera Sainz

Horizonte Sanitario November 11, 2025 DOI: 10.19136/hs.a24n3.6061 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Quasi-experimental pilot study (pre- and post-test) Peer reviewed
Population Women aged 30 to 69 years diagnosed with breast cancer who could read and write, had an electronic device with internet access, and had mild or higher levels of anxiety
Duration 8-week intervention
Topics Anxiety
Keywords Wilcoxon signed-rank test Intervention counseling Breast cancer Test biology Pilot test Research design Clinical psychology Physical therapy Program evaluation The internet
Key findings The intervention program showed feasibility and participant-reported benefits, but the preliminary effect did not show significant differences in pre- and post-intervention anxiety measurements using the Wilcoxon test.

Abstract

Objective: To explore the feasibility of the intervention “Mindfulness to Reduce Anxiety in Women with Breast Cancer.”

Materials and Methods: A pilot study with a quasi-experimental design (pre- and post-test) was conducted. The sample consisted of women aged 30 to 69 years diagnosed with breast cancer who could read and write, had an electronic device with internet access, and had mild or higher levels of anxiety as determined by the Generalized Anxiety Scale. The intervention program lasted eight weeks and consisted of twelve sessions, eight in person and four virtual. Data were collected using a field diary, checklists, and Fabricio's (2013) Acceptability and Feasibility Scale. The study complied with the General Health Law on Research Involving Human Beings (2024).

Results: Participants had a mean age of 52.71 years and an average of 13.86 years of schooling. Regarding feasibility, participants reported that the sessions, program duration, procedures used, and program content were sufficient, as was the program's ability to reduce anxiety. They also reported good acceptance and satisfaction with the program. However, although benefits were observed in the participants, the preliminary effect did not show significant differences in pre- and post-intervention measurements using the Wilcoxon test (p=156).

Conclusions: The results of the pilot study allow us to conclude that the intervention program showed feasibility and offered benefits to its participants after eight weekly sessions. Therefore, it is recommended to test its delivery with a larger number of participants to begin exploring its effect. Keywords: Feasibility; Breast cancer; Mindfulness; Anxiety.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Explore topics